LD-2 disclosure · 3rd Quarter - Report
WELCH ALLYN, INC.
Client
- Name
- WELCH ALLYN, INC.
- Description
- Medical device manufacturer
- Location
- New York · United States of America
Registrant
- Description
- Law firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
5 issuesTaxation/Internal Revenue Code
Medical device tax; IC-DISC; implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); H.R. 160/S. 149; FY 2016 budget; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act
LobbyistsMARTHA KENDRICK · ELI TOMAR · mrs KENDALL BYRUM HUSSEY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Telecommunications
Health information technology issues; telemedicine and connected care; rural telemedicine; implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); FY 2016 budget; remote patient monitoring; 21st Century Cures (H.R. 6)
LobbyistsMARTHA KENDRICK · ELI TOMAR · mrs CAITLIN SUZANNE MCCORMICK · mrs KENDALL BYRUM HUSSEY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; community health centers and school health; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 160/S. 149); accountable care organizations; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act; FY 2016 budget; Sunshine Act/Open Payment implementation; 21st Century Cures Act (H.R. 6); The Medicare Access and CHIP Reauthorization Act (H.R. 2); Medicare Telehealth Parity Act (H.R. 2948)